Evidence map›Paper›PMID 32161475›Full record

ArticleInfection and drug resistance2020

Sujiraphong Pharkjaksu, Piriyaporn Chongtrakool, Methee Chayakulkeeree, Chalermchai Mitrpant, Pornpimon Angkasekwinai, John E Bennett, Kyung J Kwon-Chung, Popchai Ngamskulrungroj

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Optimizing antifungal dosing for invasiveFrontiers in pharmacology · 2025
    Article
  2. Antifungal Resistance in Cryptococcal Infections.Pathogens (Basel, Switzerland) · 2024
    Review
  3. Article
  4. Methods for Antifungal Susceptibility Testing of theJournal of fungi (Basel, Switzerland) · 2023
    Review
  5. ATI-2307 Exhibits Equivalent Antifungal Activity inFrontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sujiraphong PharkjaksuDepartment of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-6831-5303
Piriyaporn ChongtrakoolDepartment of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0003-4208-2422
Methee ChayakulkeereeDivision of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-4582-4914
Chalermchai MitrpantDepartment of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pornpimon AngkasekwinaiDepartment of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.
John E BennettLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Kyung J Kwon-ChungLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Popchai NgamskulrungrojDepartment of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0001-5162-5498
Siriraj Hospital · THNational Institutes of Health · USThammasat University · TH

Funding

Pathogenic differences between Cryptococcus neoformans and C. gattiiZIAAI000744 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KWON-CHUNG, KYUNG · 2010 to 2025
$10.9M
6 · The paper itself

Abstract

introductionThe

methodsWe determined the in vitro antifungal susceptibility patterns of 233

resultsThe 233

conclusionThe high rate of non-wild-type among these otherwise naive isolates to amphotericin B is unexpected. Confirmation with more strains from a later era is needed.

Indexed as

antifungal susceptibilityCryptococcus neoformans/gattii species complexesepidemiologic cutoff valuesgenotypenon-wild typepre-HIV pandemic

Identifiers

PMID32161475
PMCPMC7049752
OpenAlexW3008971975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.